Is Wixela Inhub the same as Advair Diskus?
How does Wixela Inhub compare to Advair Diskus in price?
Medically reviewed by Drugs.com. Last updated on Sep 10, 2019.
Wixela Inhub is the first approved generic version of Advair Diskus. It is therapeutically equivalent to Advair Diskus.
Wixela Inhub and Advair Diskus (fluticasone propionate and salmeterol inhalation powder, USP) are combination products containing a corticosteroid and a long-acting beta2-adrenergic agonist indicated for:
- Twice-daily treatment of asthma in patients aged 4 years and older.
- Maintenance treatment of airflow obstruction and reducing exacerbations in patients with chronic obstructive pulmonary disease (COPD).
Wixela Inhub and Advair Diskus are NOT indicated for relief of acute bronchospasm.
Both Wixela Inhub and Advair Diskus are supplied as inhalers containing powder for inhalation in the following strengths:
- fluticasone propionate 100 mcg and salmeterol 50 mcg
- fluticasone propionate 250 mcg and salmeterol 50 mcg
- fluticasone propionate 500 mcg and salmeterol 50 mcg
Advair Diskus was first approved by the FDA in August 2000.
Wixela Inhub was first approved by the FDA in January 2019.
Generic products in general provide significant cost savings compared to the brand name product.
For more information on pricing see:
Related Medical Questions
- Symbicort vs. Advair: How do they compare?
- Can vitamin C prevent or treat COVID-19 (coronavirus)?
- What is the difference between emphysema and COPD?
- What are some alternatives for Trelegy Ellipta?
- What does Symbicort do to the lungs?
- Trelegy vs. Breo: How do they compare?
- How long can you be on Symbicort?